<DOC>
	<DOCNO>NCT00118508</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness weekly risedronate prevention treatment bone loss premenopausal newly menopausal woman breast cancer receive chemotherapy . The hypothesis bisphosphonate therapy prevent bone loss clinically relevant site , hip spine . The investigator also hypothesize correlation biochemical marker bone turnover change bone mineral density .</brief_summary>
	<brief_title>The Prevention Osteoporosis Premenopausal Newly Postmenopausal ( Up 8 Years ) Women With Breast Cancer Following Chemotherapy ( REBBeCA Study )</brief_title>
	<detailed_description>Breast cancer significant public health problem accounting approximately 30 % new cancer diagnose annually . Much advancement make treatment cancer significantly decrease mortality rate . Treatment , include adjuvant chemotherapy hormonal therapy , prolongs disease free survival overall survival patient breast cancer . The cytotoxic drug , however , cause premature ovarian failure subsequent menopause . This risk report range 53 % 89 % . Temporary permanent chemotherapy induce ovarian failure important potential bone loss associate estrogen loss . Initiating potent antiresorptive agent , risedronate , prevent improve bone mass woman . Comparison : The investigator compare bone mass/markers study subject receive risedronate study subject receive placebo . All subject provide calcium vitamin D supplementation need .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Pre newly postmenopausal ( 8 year ) woman age 18 old Breast cancer treat chemotherapeutic agent , without tamoxifen/aromatase inhibitor Negative pregnancy test Stage 4 breast cancer Any illness medication know affect bone metabolism History osteoporosis history vertebral hip fracture Kidney stone past 5 year Active peptic ulcer disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>